Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3710

1.

Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.

Savaskan E, Mueller H, Hoerr R, von Gunten A, Gauthier S.

Int Psychogeriatr. 2017 Sep 21:1-9. doi: 10.1017/S1041610217001892. [Epub ahead of print]

PMID:
28931444
2.

The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders.

Bruins J, Jörg F, van den Heuvel ER, Bartels-Velthuis AA, Corpeleijn E, Muskiet FAJ, Pijnenborg GHM, Bruggeman R.

Schizophr Res. 2017 Sep 16. pii: S0920-9964(17)30536-4. doi: 10.1016/j.schres.2017.08.059. [Epub ahead of print] No abstract available.

PMID:
28927862
3.

Interpersonal sensitivity and persistent attenuated psychotic symptoms in adolescence.

Masillo A, Brandizzi M, Valmaggia LR, Saba R, Lo Cascio N, Lindau JF, Telesforo L, Venturini P, Montanaro D, Di Pietro D, D'Alema M, Girardi P, Fiori Nastro P.

Eur Child Adolesc Psychiatry. 2017 Sep 16. doi: 10.1007/s00787-017-1047-2. [Epub ahead of print]

PMID:
28918440
4.

Psychodynamic day treatment programme for patients with schizophrenia spectrum disorders: Dynamics and predictors of therapeutic change.

Pec O, Bob P, Pec J, Hrubcova A.

Psychol Psychother. 2017 Sep 13. doi: 10.1111/papt.12153. [Epub ahead of print]

PMID:
28901691
5.

Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community.

Schultze-Lutter F, Michel C, Ruhrmann S, Schimmelmann BG.

Psychol Med. 2017 Sep 11:1-15. doi: 10.1017/S0033291717002586. [Epub ahead of print]

PMID:
28889802
6.

Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis.

Joaquim HPG, Zanetti MV, Serpa MH, Van de Bilt MT, Sallet PC, Chaim TM, Busatto GF, Gattaz WF, Talib LL.

Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30538-8. doi: 10.1016/j.schres.2017.08.062. [Epub ahead of print]

PMID:
28888361
7.

An examination of components of recovery after five years of treatment in an early intervention program for psychosis.

Norman RMG, MacDougall A, Manchanda R, Harricharan R.

Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30531-5. doi: 10.1016/j.schres.2017.08.054. [Epub ahead of print]

PMID:
28888360
8.

Prediction of self-stigma in early psychosis: 3-Year follow-up of the randomized-controlled trial on extended early intervention.

Ho RWH, Chang WC, Kwong VWY, Lau ESK, Chan GHK, Jim OTT, Hui CLM, Chan SKW, Lee EHM, Chen EYH.

Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30544-3. doi: 10.1016/j.schres.2017.09.004. [Epub ahead of print]

PMID:
28888358
9.

Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety.

Lu Y, Marshall C, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J.

Psychiatry Res. 2017 Aug 31. pii: S0165-1781(17)30315-3. doi: 10.1016/j.psychres.2017.08.045. [Epub ahead of print]

PMID:
28886901
10.

Stigma Resistance in Stable Schizophrenia: The Relative Contributions of Stereotype Endorsement, Self-Reflection, Self-Esteem, and Coping Styles.

Kao YC, Lien YJ, Chang HA, Tzeng NS, Yeh CB, Loh CH.

Can J Psychiatry. 2017 Jan 1:706743717730827. doi: 10.1177/0706743717730827. [Epub ahead of print]

PMID:
28884606
11.

Treatment of Depression: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2004 Mar.

12.

Premorbid social adjustment and association with attenuated psychotic symptoms in clinical high-risk and help-seeking youth.

Tarbox-Berry SI, Perkins DO, Woods SW, Addington J.

Psychol Med. 2017 Sep 6:1-15. doi: 10.1017/S0033291717002343. [Epub ahead of print]

PMID:
28874223
13.

Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.

Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T.

Health Technol Assess. 2017 Sep;21(49):1-56. doi: 10.3310/hta21490.

14.

A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease.

Reeves S, Bertrand J, McLachlan E, D'Antonio F, Brownings S, Nair A, Greaves S, Smith A, Dunn JT, Marsden P, Kessler R, Uchida H, Taylor D, Howard R.

J Clin Psychiatry. 2017 Jul;78(7):e844-e851. doi: 10.4088/JCP.16m11216.

PMID:
28858444
15.

An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility.

Pos K, de Wit IE, van Dijk FA, Bartels-Velthuis AA, Bruggeman R, Meijer CJ, de Haan L; for Group; Genetic Risk and Outcome of Psychosis investigators, Alizadeh BZ, Bartels-Velthuis AA, Van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NE, van Os J, van Winkel R.

Psychiatry Res. 2017 Aug 18. pii: S0165-1781(16)31386-5. doi: 10.1016/j.psychres.2017.08.017. [Epub ahead of print]

PMID:
28851542
16.

Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.

Welter S, Lücke C, Lam AP, Custal C, Moeller S, Sörös P, Thiel CM, Philipsen A, Müller HHO.

Eur Addict Res. 2017 Aug 25;23(4):182-193. doi: 10.1159/000479554. [Epub ahead of print]

PMID:
28848170
17.

A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders.

van Rooijen G, Isvoranu AM, Kruijt OH, van Borkulo CD, Meijer CJ, Wigman JTW, Ruhé HG, de Haan L; GROUP investigators.

Schizophr Res. 2017 Aug 22. pii: S0920-9964(17)30446-2. doi: 10.1016/j.schres.2017.07.035. [Epub ahead of print]

PMID:
28844638
18.
19.
20.

Early maladaptive schemas associated with dimensional and categorical psychopathology in patients with borderline personality disorder.

Frías Á, Navarro S, Palma C, Farriols N, Aliaga F, Salvador A, Aluco E, Martínez B, Solves L.

Clin Psychol Psychother. 2017 Aug 17. doi: 10.1002/cpp.2123. [Epub ahead of print]

PMID:
28833873

Supplemental Content

Loading ...
Support Center